Genmab
GMAB
#1408
Rank
A$19.30 B
Marketcap
$30.44
Share price
-4.42%
Change (1 day)
-31.76%
Change (1 year)

EPS for Genmab (GMAB)

EPS in 2023 (TTM): $1.53

According to Genmab's latest financial reports the company's current EPS (TTM) is $1.67. In 2022 the company made an earnings per share (EPS) of $1.93 an increase over its 2021 EPS that were of $1.19.

EPS history for Genmab from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.53-20.76%
2022$1.9362.07%
2021$1.19-35.78%
2020$1.85119.14%
2019$0.8436.35%
2018$0.6229.83%
2017$0.480.92%
2016$0.4747.69%
2015$0.32109.32%
2014$0.15134.03%
2013$0.06535-121.08%
2012-$0.31-23.69%
2011-$0.4194.77%
2010-$0.21-70.48%
2009-$0.71